Randomized Controlled Trial of Rivaroxaban Plus Dual Antiplatelet Therapy versus Dual Antiplatelet Therapy Alone for Prevention of Left Ventricular Thrombus Formation after Acute Myocardial Infarction. Pjmcr. 2025;4(4):2832-2840. doi:10.66021/pakmcr1119